
Sotiktuzem 6 mg (ducravacitinib)
6mg
Tablet · Prescription medication
(Co., Ltd.) HanKook BMS Pharmaceutical
Dukrabacitinib is an ingredient used for the treatment of autoimmune diseases by regulating the immune response.
MFDS ingredient code M283457
Dukrabacitinib is a selective tyrosine kinase 2 inhibitor, a medication that regulates immune system signaling pathways. It is primarily used in the treatment of autoimmune diseases and plays a role in inhibiting the excessive activation of immune cells.
Dukrabacitinib selectively inhibits specific enzymes involved in intracellular signaling of immune cells, thereby regulating the immune response. This helps to reduce inflammation and autoimmune responses, alleviating symptoms.
Approved uses differ by product. Check each product's information for its actual use.
Dukrabacitinib is characterized by selectively inhibiting only specific signaling pathways, unlike conventional non-specific immunosuppressants, which reduces the risk of side effects. This allows for more precise immune modulation.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.